ArticleInternational journal of laboratory hematology2025
Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology.
Article in International journal of laboratory hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Determination of Fibrinogen Ratio Cutoff Limits Using Indirect Reference Interval Methodology.International journal of laboratory hematology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiscordant fibrinogen antigen to activity ratios are utilized by clinicians as evidence of dysfibrinogenemia. Abnormal ratio cutoffs implemented by clinical laboratories are typically determined by validation studies that include limited numbers of samples. We here utilize large datasets of stored clinical results and apply indirect reference interval (RI) methodology to determine fibrinogen ratio cutoffs suggestive of dysfibrinogenemia.
methodsPanel results comprised of fibrinogen antigen and activity measurements and calculated ratios of antigen to activity were retrieved for analysis. Two datasets were analyzed: (1) 3693 unique patient results in which antigen concentrations were measured by radial immunodiffusion (RID) from January 2019 to April 2023, and (2) 2192 patient results with antigen concentrations measured using turbidimetry immunoassay between April 2024 and March 2025. Both datasets were analyzed using the RefineR algorithm to estimate the corresponding RI of fibrinogen activity and antigen, and ratio cutoffs.
resultsEstimated fibrinogen antigen/activity ratio cutoffs were within close range (< 8% difference) to the validated cutoffs used by our laboratory: 1.17 versus 1.23 and 1.06 versus 1.01 using antigen RID and turbidimetry assays, respectively. Contrarily, estimated upper RI limits of antigen and activity were higher by 38.4%-57.2% than validated limits, and RI was wider by 41.8%-76%.
conclusionThe RefineR algorithm could be used to determine fibrinogen ratio cutoffs with the advantage of including significantly larger numbers of available clinical results. For antigen and activity, the algorithm could not separate out acute-phase elevated fibrinogen (activity and antigen) results and overestimated the upper RI limits relative to the clinically validated cutoffs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.